The structural inefficiency of the U.S. public health insurance model creates a $76 billion annual cost premium and an unfunded liability risk that undermines its viability as a scalable template for universal coverage.
From a cost structure and efficiency perspective, the current Medicare framework exhibits significant operational friction that erodes value for both the payer and the beneficiary. Yale SOM Professor Howard P. Forman highlights that traditional fee-for-service Medicare imposes a fragmented cost burden, including a $1,736 hospital deductible per benefit period and 20% co-insurance with no out-of-pocket cap for physician and hospital care. This lack of a unified cost ceiling creates unpredictable unit economics for beneficiaries, where deductibles and premiums can consume up to 12% of income for lower-income enrollees. For corporate treasury and enterprise risk functions, this volatility mirrors the challenges of managing variable operational expenses without clear budgetary controls, leading to potential liquidity shocks for individuals and, by extension, increased societal risk that can impact labor stability and consumer confidence.
In the realm of capital allocation and ROI, the shift toward Medicare Advantage represents a significant reallocation of public funds with questionable efficiency gains. MedPAC estimates that Medicare pays approximately 14% more for Medicare Advantage enrollees compared to traditional Medicare, amounting to roughly $76 billion annually. This premium funds private plan perks rather than core clinical value, creating a negative NPV scenario for the public trust fund. The Part A trust fund, which covers hospital care, is projected to become insolvent by 2033, signaling a severe funding gap that requires immediate structural intervention. For executives analyzing market dynamics, this demonstrates how market segmentation into private alternatives can drive up run-rate costs without delivering proportional improvements in service delivery or health outcomes, a dynamic often seen in M&A where synergy targets are missed due to integration complexities.
Governance and compliance failures are evident in the complexity of the current system, where 87% of beneficiaries require supplemental insurance to manage costs. This reliance on private Medigap plans introduces adverse selection risks, particularly given the limited enrollment windows that can lock out individuals. The proposed fixes—such as a $5,000 out-of-pocket cap (estimated at $16 billion in annual cost) and aligning Medicare Advantage payments with traditional rates—aim to restore fiduciary discipline to the program. By capping catastrophic exposure and standardizing co-insurance rates, the system would reduce the operational risk of financial ruin for the elderly and disabled, thereby stabilizing the broader social contract that underpins the labor market.
The strategic implication of these findings is that the current Medicare model suffers from structural misalignment between its public mandate and its private delivery mechanisms, resulting in capital inefficiency and fiscal unsustainability. For boards and C-suite executives, this serves as a cautionary case study in how fragmented governance and opaque cost structures can erode the value proposition of a large-scale public program. The trade-off between maintaining private plan incentives and ensuring fiscal solvency is likely to sharpen as the trust fund depletion date approaches, necessitating a re-evaluation of how public resources are allocated to maximize social ROI. Whether this model can be generalized to a universal system remains an open question, but the evidence suggests that without first resolving the unit economics and risk management flaws in the existing program, any expansion would compound rather than mitigate systemic financial risks.